MCID/Low Disease Activity State Workshop: summary, recommendations, and research agenda.

Wells, George; Anderson, Jennifer; Boers, Maarten; Felson, David; Heiberg, Turid; Hewlett, Sarah; Johnson, Kent; Kirwan, John et al. · J Rheumatol · 2003

review · Level V

Where this comes from

Abstract

The OMERACT 6 Minimal Clinically Important Difference/Low Disease Activity Workshop was organized with the aim of meeting the many challenges that exist in determining a low disease activity in rheumatoid arthritis (RA). This article presents an overview of that workshop, including results of the voting, a summary of associated discussions, recommendations, and a proposed research agenda.

Medical subject headings